Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL QUINAZOLINE COMPOUND AS KRAS INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/063576
Kind Code:
A1
Abstract:
The present invention relates to a novel quinazoline compound as a KRAS inhibitor and, more specifically, to a novel quinazoline compound useful as a KRAS protein inhibitor, an isomer, and a pharmaceutical composition for cancer treatment comprising same.

Inventors:
HONG CHANG HEE (KR)
LEE JIN HEE (KR)
LEE JOO YUN (KR)
PARK JONG SEON (KR)
KIM JIN WOONG (KR)
HONG SOO JUNG (KR)
HONG SUNG JUN (KR)
SONG HAENG JIN (KR)
YOON HONG CHUL (KR)
AN KYUNG MI (KR)
PARK JOON TAE (KR)
LEE JUNG WOO (KR)
Application Number:
PCT/KR2023/014439
Publication Date:
March 28, 2024
Filing Date:
September 21, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ILDONG PHARMACEUTICAL CO LTD (KR)
International Classes:
C07D487/04; A61K31/517; A61K31/551; A61K31/553; A61K31/554; A61P35/00; C07D401/14; C07D413/14; C07D417/14; C07D471/04
Domestic Patent References:
WO2022173870A12022-08-18
WO2022105855A12022-05-27
WO2022177917A22022-08-25
WO2021108683A12021-06-03
Foreign References:
KR20210006948A2021-01-19
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: